Related Experiment Videos
A pharmacodynamic model for soman in the rat
D M Maxwell1, C P Vlahacos, D E Lenz
1United States Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD 21010-5425.
Toxicology Letters
|October 1, 1988
Summary
This study developed a pharmacodynamic model to understand how soman inhibits acetylcholinesterase (AChE). Soman metabolism in plasma significantly impacts AChE inhibition in the brain.
Area of Science:
- Pharmacology
- Toxicology
- Biochemistry
Background:
- Acetylcholinesterase (AChE) is crucial for nerve function.
- Soman is an organophosphate nerve agent that inhibits AChE.
- Understanding AChE inhibition dynamics is vital for predicting soman toxicity.
Purpose of the Study:
- To develop a pharmacodynamic model for AChE inhibition by soman.
- To describe intertissue differences in AChE inhibition.
- To investigate the influence of xenobiotic metabolism on soman toxicity.
Main Methods:
- Physiological pharmacokinetic principles were applied.
- A set of mass balance equations formed the model.
- Parameters included blood flow, tissue volumes, metabolism, partition coefficients, and AChE levels.
Main Results:
- The model described dose-response relationships for AChE inhibition.
- Sensitivity analysis identified key determinants of inhibition.
- Plasma soman metabolism was the most critical factor affecting brain AChE inhibition.
Conclusions:
- The developed model accurately describes AChE inhibition by soman.
- Xenobiotic metabolism significantly modulates soman's toxic effects.
- Targeting plasma metabolism could be a strategy to mitigate soman toxicity.